Search Results
Debate: Which is the optimal approach for CLL? - FCR
Debate: Which is the optimal approach for CLL? - BR
Debate: Optimal approach for the management of CLL patients with del(17p) - Ibrutinib
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents
Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - Ibrutinib
Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - FCR
Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Kinase inhibitor
Debate: Should young patients with mantle cell lymphoma be treated aggressively? - Yes
Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - ASCT
Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Other Novel Agents
Debate: Do we have enough data to eliminate chemotherapy from initial treatment for CLL? - No
Debate: Do we have enough data to eliminate chemotherapy from initial treatment for CLL? - Yes
